Clear Harbor Asset Management’s Cellebrite CLBT Stock Holding History

Clear Harbor Asset Management’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-17,392	Closed	-$106K	–	371
2023 Q1	$106K	Buy	17,392 +1,500	+9%	+$8.13K	0.01%	360
2022 Q4	$69.3K	Buy	+15,892	New	+$71K	0.01%	345

Other funds holding CLBT

True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return

Crosslink Capital Menlo Park, California $1.35B AUM 35.86% 1-Year Est. Return

Isomer Partners New York $74.3M AUM 23.95% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Light Street Capital Management Palo Alto, California $903M AUM 113.12% 1-Year Est. Return

Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Makena Capital Management Menlo Park, California $952M AUM 13.93% 1-Year Est. Return

Clear Harbor Asset Management's CLBT Position: Q2 2023 in Review

Clear Harbor Asset Management sold out of Cellebrite (CLBT) in Q2 2023, closing a stake of 17,392 shares — an estimated $106K sold.

Clear Harbor Asset Management first reported a position in CLBT in Q4 2022 and held it in 2 quarters. The position peaked at $106K in Q1 2023. 78 funds tracked by Wall St. Rank hold CLBT as of Q2 2023.

Clear Harbor Asset Management reported no remaining Cellebrite position as of Q2 2023 after selling out during the quarter.
Clear Harbor Asset Management sold 17,392 Cellebrite shares in Q2 2023, an estimated $106K.
Clear Harbor Asset Management first reported a position in Cellebrite in Q4 2022 and held it in 2 quarters.
Clear Harbor Asset Management's Cellebrite position peaked at $106K in Q1 2023.
78 funds tracked by Wall St. Rank held Cellebrite as of Q2 2023.

Based on Clear Harbor Asset Management's 13F filing for Q2 2023, filed 21 Jul 2023.